Valneva travel vaccines explained for US-bound trips

Valneva travel vaccines are used to help protect travelers from specific infectious diseases that occur in defined regions worldwide, according to the companys product information for cholera and Japanese encephalitis vaccines Valneva, 03/2025 and an overview of marketed vaccines Valneva, 02/2025.

Updated: 05/19/2026 | Reading time: approx. 6 minutes

By the AD HOC NEWS editorial team - specialized in product-led market coverage.

What Valneva travel vaccines are and how they work

Valneva travel vaccines are inactivated and oral vaccines designed for diseases such as cholera and Japanese encephalitis, based on the companys product portfolio description Valneva, 03/2025 and its corporate overview of marketed vaccines Valneva, 02/2025.

Inactivated vaccines typically use killed pathogens, and oral vaccines deliver antigens through the digestive tract, as outlined in general vaccine explanations by the US Centers for Disease Control and Prevention CDC, 01/2025 together with basic vaccine type descriptions CDC, 11/2024.

According to Valnevas public product information, its travel portfolio includes vaccines intended for prevention of cholera and Japanese encephalitis in at risk individuals traveling to endemic areas, administered under guidance of healthcare professionals Valneva, 03/2025 supported by the companys description of its travel vaccine heritage Valneva, 02/2025.

Why Valneva travel vaccines matter for consumers and industry

The US CDC notes that cholera and Japanese encephalitis remain relevant travel associated diseases in specific regions, and recommends vaccination for some travelers depending on itinerary and exposure risk CDC, 12/2024 together with destination specific travel health guidance CDC, 01/2025.

For US travelers planning trips to rural parts of Asia or to areas with poor sanitation, the availability of targeted travel vaccines can support pre travel medical planning with physicians or travel clinics, as emphasized in CDC resources on pre travel consultations CDC, 10/2024 and in its Yellow Book guidance for clinicians CDC, 07/2024.

On the industry side, Valneva states that travel and endemic vaccines form a core part of its commercial business and expertise in preventive medicine, with a focus on diseases that are often overlooked but remain important for travelers and specific populations Valneva, 02/2025 as well as commentary in its product overview on serving specialized vaccine markets Valneva, 03/2025.

Valneva travel vaccines in the US and global market

The CDC explains that multiple manufacturers supply cholera and Japanese encephalitis vaccines globally, and that product availability varies by country based on regulatory approvals and local recommendations CDC, 11/2024 together with travel vaccine access guidance for US residents CDC, 12/2024.

Valneva states that its travel vaccine products are marketed in various territories subject to local authorization, via distribution partnerships and direct commercialization in selected markets, including within North America and Europe where approvals are in place Valneva, 03/2025 in combination with business segment information from its corporate pages Valneva, 02/2025.

US travelers typically access travel vaccines through clinics, pharmacies, or physicians who source products from licensed distributors, consistent with CDC advice that vaccinations for international travel should be coordinated with healthcare providers familiar with destination specific guidance CDC, 09/2024 and its explanation of how to locate authorized travel clinics in the United States CDC, 09/2024.

• Vaccines target cholera and Japanese encephalitis in defined regions.
• Products are prescribed by healthcare professionals based on travel risk.
• US travelers discuss these vaccines in pre travel consultations.
• Availability varies by country and regulatory approval status.

Frequently Asked Questions About Valneva travel vaccines

Which diseases do Valneva travel vaccines address?
According to the companys product overview, Valneva markets vaccines for diseases such as cholera and Japanese encephalitis in travelers to endemic regions Valneva, 03/2025 supported by its description of travel vaccine markets Valneva, 02/2025.

How should US travelers plan vaccinations with these products?
The CDC recommends that US travelers consult health professionals ideally four to six weeks before departure to review vaccine needs based on itinerary, using vaccines supplied by licensed manufacturers CDC, 10/2024 and clinic finder guidance for US residents CDC, 09/2024.

Are Valneva travel vaccines available without prescription?
Valneva explains that its vaccines are prescription medicines supplied to healthcare professionals and that patients should seek advice from qualified providers, in line with general practice that travel vaccines are given under medical supervision Valneva, 03/2025 and supported by CDC travel medicine practice notes CDC, 07/2024.

Valneva SE is a specialty vaccine company focused on developing and commercializing vaccines for infectious diseases, including travel vaccines for selected conditions in at risk populations, as outlined on its corporate site Valneva, 02/2025.

Valneva SE shares are listed on Euronext Paris and Nasdaq under the ticker VALN, and the companys securities carry the international securities identification number FR0013280286, according to its investor relations information Valneva, 03/2025.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.